54gene is a healthcare startup that offers a genetics testing platform.
54gene is a healthcare startup unlocking the African genome to fuel genetic research and development that may lead to new discoveries and benefit all populations.
54gene was founded in 2019 by Dr. Abasi Ene-Obong to address the significant gap in the global genomics market: Nearly 90% of genetic material used in pharmaceutical research is caucasian. Only 2% is African, despite the fact that Africans and people of African ancestry are more genetically diverse than all other world populations combined. As a result, pharmaceutical research and development is lacking the diverse data that may hold the key to medical discoveries and new healthcare solutions.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Oct 28, 2022 | Convertable Note | $50M | 7 | — | — | Detail |
Sep 16, 2021 | Series B | $25M | 8 |
![]() |
— | Detail |
Aug 15, 2021 | Series A | — | 1 | — | — | Detail |
Aug 15, 2021 | Series A | — | — | — | — | Detail |
Jul 23, 2021 | Funding Round | $75K | 1 | — | — | Detail |
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Sep 14, 2022
![]() |
Series A | $42M | Biotechnology | — |
Aug 30, 2022
![]() |
Seed | $5M | Blockchain | — |
Aug 1, 2022
![]() |
Post-IPO Equity | $100M | Artificial Intelligence | — |
Apr 25, 2022
![]() |
Seed | $1.30M | Blockchain | — |
Apr 20, 2022
![]() |
Pre-seed | $1.50M | Content | — |
Investor Name | Lead Investor | Funding Round |
---|---|---|
![]() |
— | Convertable Note |
![]() |
— | Convertable Note |
![]() |
— | Convertable Note |
![]() |
— | Convertable Note |
![]() |
— | Convertable Note |
![]() |
— | Convertable Note |
![]() |
— | Convertable Note |
![]() |
— | Series B |
![]() |
— | Series A |
![]() |
— | Funding Round |